ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
AYTU BioPharma Inc

AYTU BioPharma Inc (AYTU)

1,47
-0,02
( -1,34% )
Aktualisiert: 19:33:54

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
1,47
Gebot
1,47
Fragen
1,48
Volumen
12.333
1,45 Tagesbereich 1,55
1,41 52-Wochen-Bereich 3,45
Marktkapitalisierung
Handelsende
1,49
Handelsbeginn
1,5103
Letzte Trade
51
@
1.47
Letzter Handelszeitpunkt
19:28:49
Finanzvolumen
US$ 18.442
VWAP
1,4953
Durchschnittliches Volumen (3 Mio.)
29.577
Ausgegebene Aktien
6.149.369
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,59
Gewinn pro Aktie (EPS)
-2,58
Erlöse
81M
Nettogewinn
-15,84M

Über AYTU BioPharma Inc

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complimen... Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complimentary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
AYTU BioPharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AYTU. The last closing price for AYTU BioPharma was US$1,49. Over the last year, AYTU BioPharma shares have traded in a share price range of US$ 1,41 to US$ 3,45.

AYTU BioPharma currently has 6.149.369 shares in issue. The market capitalisation of AYTU BioPharma is US$9,16 million. AYTU BioPharma has a price to earnings ratio (PE ratio) of -0.59.

AYTU Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.25-14.53488372091.721.7651.41663491.55610081CS
4-0.64-30.33175355452.112.231.41450181.72914222CS
12-0.93-38.752.42.851.41295772.05499692CS
26-1.55-51.32450331133.023.241.41252912.39739769CS
52-0.97-39.75409836072.443.451.41234132.62501499CS
156-39.33-96.397058823540.8481.3837605910.31854915CS
260-13.976-90.48297293815.446235.2861.38217285234.74658885CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
WORXSCWorx Corporation
US$ 2,04
(108,16%)
126,87M
CRNCCerence Inc
US$ 5,7206
(102,86%)
54,7M
SPAISafe Pro Group Inc
US$ 4,57
(42,81%)
38,81M
PROCProcaps Group SA
US$ 0,7792
(36,34%)
952,41k
ARQQArqit Quantum Inc
US$ 10,00
(36,24%)
502,01k
SKKSKK Holdings Limited
US$ 1,43
(-68,64%)
16,63M
TMTCTMT Acquisition Corporation
US$ 2,27
(-64,75%)
171,1k
WCTWellchange Holdings Company Limited
US$ 1,31
(-60,54%)
1,4M
GLXGGalaxy Payroll Group Ltd
US$ 2,06
(-47,31%)
2,02M
PYXSPyxis Oncology Inc
US$ 2,125
(-44,37%)
12,28M
CDTConduit Pharmaceuticals Inc
US$ 0,1126
(21,99%)
540,05M
NVDANVIDIA Corporation
US$ 146,0552
(0,11%)
267,83M
ELABElevai Labs Inc
US$ 0,0206
(-3,74%)
197,59M
AKTSAkoustis Technologies Inc
US$ 0,1037
(19,06%)
195,11M
WORXSCWorx Corporation
US$ 2,04
(108,16%)
126,87M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht